Cullinan Oncology, Inc.
Total Trades
87
Buys
5
Sells
73
Largest Trade
$1M+
Insiders
11
Institutional Funds
111
Inst. Value
$1M+
Activist Filings
32
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Michaelson Jennifer | Chief Development … | SELL | $100K–$500K | 12K | $12.31 | Jun 8, 2023 |
| Michaelson Jennifer | Chief Development … | EXERCISE | $50K–$100K | 12K | $4.30 | Jun 8, 2023 |
| AHMED NADIM | President and CEO | SELL | $1K–$15K | 707 | $9.15 | May 24, 2023 |
| Michaelson Jennifer | Chief Development … | SELL | $1K–$15K | 239 | $8.76 | May 19, 2023 |
| Jones Jeffrey Alan | Chief Medical Offi… | SELL | $1K–$15K | 394 | $8.76 | May 19, 2023 |
| SUMER JACQUELYN L | Chief Legal Officer | SELL | $1K–$15K | 291 | $8.76 | May 19, 2023 |
| Trigilio Jeffrey | CFO | SELL | $1K–$15K | 399 | $8.76 | May 19, 2023 |
| Michaelson Jennifer | Chief Development … | SELL | $1K–$15K | 193 | $8.78 | May 16, 2023 |
| Trigilio Jeffrey | CFO | SELL | $1K–$15K | 347 | $8.78 | May 16, 2023 |
| AHMED NADIM | President and CEO | SELL | $1K–$15K | 716 | $10.59 | Apr 26, 2023 |
| Jones Jeffrey Alan | Chief Medical Offi… | SELL | $1K–$15K | 392 | $10.71 | Apr 20, 2023 |
| Trigilio Jeffrey | CFO | SELL | $1K–$15K | 398 | $10.71 | Apr 20, 2023 |
| Michaelson Jennifer | Chief Development … | SELL | $1K–$15K | 238 | $10.71 | Apr 20, 2023 |
| SUMER JACQUELYN L | Chief Legal Officer | SELL | $1K–$15K | 290 | $10.71 | Apr 20, 2023 |
| Trigilio Jeffrey | CFO | SELL | $1K–$15K | 318 | $10.22 | Apr 14, 2023 |
| Michaelson Jennifer | Chief Development … | SELL | $1K–$15K | 176 | $10.22 | Apr 14, 2023 |
| Trigilio Jeffrey | CFO | SELL | $1K–$15K | 399 | $11.32 | Mar 27, 2023 |
| Jones Jeffrey Alan | Chief Medical Offi… | SELL | $1K–$15K | 390 | $11.32 | Mar 27, 2023 |
| Michaelson Jennifer | Chief Development … | SELL | $1K–$15K | 238 | $11.32 | Mar 27, 2023 |
| SUMER JACQUELYN L | Chief Legal Officer | SELL | $1K–$15K | 305 | $11.32 | Mar 27, 2023 |
| AHMED NADIM | President and CEO | SELL | $1K–$15K | 706 | $10.51 | Mar 27, 2023 |
| Michaelson Jennifer | See Remarks | SELL | $50K–$100K | 4K | $13.30 | Nov 29, 2022 |
| Michaelson Jennifer | See Remarks | EXERCISE | $15K–$50K | 4K | $4.30 | Nov 29, 2022 |
| Michaelson Jennifer | See Remarks | SELL | $15K–$50K | 4K | $12.40 | Sep 29, 2022 |
| Michaelson Jennifer | See Remarks | EXERCISE | $15K–$50K | 4K | $4.30 | Sep 29, 2022 |
| Michaelson Jennifer | Chief Development … | SELL | $15K–$50K | 1K | $15.01 | Aug 9, 2022 |
| Michaelson Jennifer | Chief Development … | EXERCISE | $1K–$15K | 1K | $4.30 | Aug 9, 2022 |
| F2 Vision SCS | 10% Owner | SELL | $500K+ | 50K | $14.26 | Aug 5, 2022 |
| Michaelson Jennifer | Chief Development … | EXERCISE | $15K–$50K | 8K | $4.30 | Jul 26, 2022 |
| Michaelson Jennifer | Chief Development … | SELL | $100K–$500K | 8K | $14.51 | Jul 26, 2022 |
| Savill Corrine | Acting Chief Busin… | SELL | $100K–$500K | 20K | $15.18 | Jul 21, 2022 |
| Savill Corrine | Acting Chief Busin… | SELL | $500K+ | 40K | $13.33 | Jul 12, 2022 |
| F2 Bioscience I 2017 Ltd | 10% Owner | SELL | $1M+ | 102K | $12.80 | Jun 23, 2022 |
| BVF PARTNERS L P/IL | 10% Owner | BUY | $1M+ | 751K | $11.00 | Jun 3, 2022 |
| F2 Vision SCS | 10% Owner | SELL | $1M+ | 419K | $9.66 | May 17, 2022 |
| BVF PARTNERS L P/IL | 10% Owner | BUY | $1M+ | 1.1M | $9.07 | May 16, 2022 |
| BVF PARTNERS L P/IL | 10% Owner | BUY | $1M+ | 276K | $10.75 | Apr 5, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 111 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| MPM BioImpact LLC | 7.6M | $1M+ | SH |
| Blue Owl Capital Holdings LP | 2.4M | $1M+ | SH |
| Blue Owl Capital Holdings LP | 2.4M | $1M+ | SH |
| STATE STREET CORP | 2.2M | $1M+ | SH |
| Affinity Asset Advisors, LLC | 1.9M | $1M+ | SH |
| VR Adviser, LLC | 1.4M | $1M+ | SH |
| Siren, L.L.C. | 1.2M | $1M+ | SH |
| Nextech Invest, Ltd. | 1.1M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 797K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 632K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 436K | $1M+ | SH |
| Point72 Asset Management, L.P. | 360K | $1M+ | SH |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 344K | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 319K | $1M+ | SH |
| ORBIMED ADVISORS LLC | 270K | $1M+ | SH |
| BARCLAYS PLC | 270K | $1M+ | SH |
| Connor, Clark & Lunn Investment Management Ltd. | 244K | $1M+ | SH |
| CITIGROUP INC | 239K | $1M+ | SH |
| PFM Health Sciences, LP | 227K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Mar 4, 2026
5.3%
3.1M shares
SC 13G · Jan 30, 2026
5.6%
3.3M shares
SC 13G/A · Nov 14, 2025
3.1%
1.8M shares
SC 13G/A · Nov 14, 2025
9.8%
5.8M shares
SC 13G/A · Nov 13, 2025
5.0%
2.9M shares
SC 13G/A · Oct 30, 2025
5.0%
2.9M shares
SC 13G/A · Oct 10, 2025
14.5%
8.5M shares
SC 13G · Aug 14, 2025
7.5%
4.4M shares
SC 13G · Aug 6, 2025
4.3%
2.5M shares
SC 13G/A · Nov 14, 2024
3.5%
2.0M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Nov 14, 2024
5.2%
3.0M shares
SC 13G/A · Nov 12, 2024
5.2%
3.0M shares
SC 13G · Nov 8, 2024
7.5%
4.3M shares
SC 13G/A · Nov 4, 2024
5.2%
3.0M shares
SC 13G/A · Oct 31, 2024
3.8%
2.2M shares
SC 13G · Oct 22, 2024
7.5%
4.3M shares
SC 13G/A · Jun 7, 2024
4.8%
2.7M shares
SC 13G · Apr 24, 2024
5.7%
3.3M shares
SC 13G · Feb 15, 2024
8.0%
3.4M shares
SC 13G/A · Feb 14, 2024
1.1%
469K shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2024
6.5%
2.9M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
4.1%
1.8M shares
SC 13G · Jan 29, 2024
5.8%
2.5M shares
SC 13G/A · Sep 7, 2023
4.8%
2.0M shares
SC 13G/A · Feb 15, 2023
3.4%
1.6M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2023
8.9%
4.1M shares
SC 13G/A · Feb 13, 2023
7.3%
3.3M shares
SC 13G · Feb 3, 2023
5.5%
2.5M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2022
6.4%
2.8M shares
Foresite Capital Fund V, L.P. (“FCF V”)
SC 13G/A · Feb 11, 2022
2.6%
1.1M shares
SC 13G · Feb 11, 2022
5.7%
2.5M shares
SC 13G · Feb 10, 2022
4.8%
2.1M shares